EUVIMEDEUVIMED entdecken
Crossref

A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity

Yishu Zhang, Jing Ma, Zhenting Zheng, Tong Fang, Huanhuan Sun, Na Li, Xiaoqing Cai iD

ACS Chemical Biology · 2026

DOI: 10.1021/acschembio.6c00123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2026. Verfasst von Yishu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, 132 East Outer Ring Road, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Erb-b2 Receptor Tyrosine Kinases, Vascular Endothelial Growth Factor A, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificErb-b2 Receptor Tyrosine KinasesVascular Endothelial Growth Factor AAntineoplastic AgentsHumansAnimalsProtein EngineeringMiceCell Line, TumorFemaleLysosomesMice, NudeImmunoglobulin GTumor MicroenvironmentXenograft Model Antitumor AssaysProteolysisTrastuzumab

Substanzen

Antibodies, BispecificErb-b2 Receptor Tyrosine KinasesVascular Endothelial Growth Factor AAntineoplastic AgentsERBB2 protein, humanImmunoglobulin GTrastuzumab

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-sen University, 132 East Outer Ring Road, Guangzhou 510006, China.

ORCID-Profile: Xiaoqing Cai

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Ma, J., Zheng, Z., Fang, T., Sun, H., Li, N., & Cai, X. (2026). A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00123

Vancouver

Zhang Y, Ma J, Zheng Z, Fang T, Sun H, Li N, et al. A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00123

BibTeX
@article{Zhang2026,
  author = {Zhang, Yishu and Ma, Jing and Zheng, Zhenting and Fang, Tong and Sun, Huanhuan and Li, Na and Cai, Xiaoqing},
  title = {A Bispecific Antibody Engineering Strategy for Effective Dual-Target Degradation of Cell-Surface and Secreted Oncoproteins with Superior Antitumor Activity},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00123}
}
Kostenlos starten →